David M. Geliebter

WPP Group USA, Inc. provides communications and media management services. The company is headquartered in New York, NY.

Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY.

Evolution Capital Management LLC (Evolution) is an independent registered investment advisor and alternative investment manager headquartered in Crystal Bay, Nevada. The firm was founded by Michael Lerch in 2002 and is a subsidiary of Tiger Trust. Evolution manages private investment funds for corporations, pension plans, foundations, trusts, estates, and high net worth individuals.

Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.

Access Scientific LLC develops vascular access devices. It offers The PICC WAND a clinically proven technique for placement of PICC-introducer/peelable sheaths. The company was founded in 2004 and is headquartered in San Diego, CA.

Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA.

Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY.

Martin Pharmaceuticals, Inc. engages in manufacturing, fabricating and processing drugs. The company was founded by David M. Geliebter and Sven M. Jacobson and is headquartered in New York, NY.

Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY.